| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/11/2010 | WO2010026966A1 Novel anti-hcv agent and use thereof |
| 03/11/2010 | WO2010026735A1 AMYLOID β AGGREGATION PROMOTION PEPTIDE AND APPLICATION THEREOF |
| 03/11/2010 | WO2010026489A1 Innate immunity modulators |
| 03/11/2010 | WO2010026483A2 Conjugate of a chitin derivative with natural sweeteners for controlling ingested fats in humans and having sweetening properties |
| 03/11/2010 | WO2010026299A1 Methods and means for soft tissue engineering |
| 03/11/2010 | WO2010026291A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 03/11/2010 | WO2010026186A1 New protecting compositions for recombinantly produced factor viii |
| 03/11/2010 | WO2010026168A2 Substances and methods for the treatment of b cell mediated multiple sclerosis |
| 03/11/2010 | WO2010025555A1 Periostin-induced pancreatic regeneration |
| 03/11/2010 | WO2010025548A1 Sperm fertility biomarkers and uses thereof |
| 03/11/2010 | WO2010025530A1 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 03/11/2010 | WO2010025510A1 Libraries of peptide conjugates and methods for making them |
| 03/11/2010 | WO2010025483A1 Treatment of fructose malabsorption |
| 03/11/2010 | WO2010009403A3 Methods for treating arthritis and other inflammatory or autoimmune diseases |
| 03/11/2010 | WO2010007494A3 New composition for the treatment of ecchymotic pigmentations |
| 03/11/2010 | WO2010007175A3 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 03/11/2010 | WO2010007144A3 Mutated netrin-4 proteins, fragments thereof and their uses as drugs |
| 03/11/2010 | WO2010002428A3 Cyclosporin analogs and their use in the treatment of hcv infections |
| 03/11/2010 | WO2009158529A8 Lyophilization cycle robustness strategy |
| 03/11/2010 | WO2009150214A3 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 03/11/2010 | WO2009149317A3 Transmucosal delivery of therapeutic agents and methods of use thereof |
| 03/11/2010 | WO2009149171A3 Fgf21 mutants and uses thereof |
| 03/11/2010 | WO2009146463A3 Variant hhip1 protein and methods and uses thereof |
| 03/11/2010 | WO2009143489A3 Modulation of angiogenesis by a-beta peptide fragments |
| 03/11/2010 | WO2009143483A9 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 03/11/2010 | WO2009143133A3 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 03/11/2010 | WO2009142727A3 Sequence modified calcitonin gene related peptides (cgrp) |
| 03/11/2010 | WO2009141731A3 The large form of human 2', 5'-oligoadenylate synthetase oas3 for preventing or treating infection with positive-sense single-stranded rna viruses |
| 03/11/2010 | WO2009136392A3 Methods and compositions for oral administration of exenatide |
| 03/11/2010 | WO2009132231A3 Peptidyl diacylglycerides |
| 03/11/2010 | WO2009129120A3 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| 03/11/2010 | WO2009122227A3 Treating cerebrovascular diseases with erythropoietin and granulocyte-colony stimulating factor jointly |
| 03/11/2010 | WO2009115809A3 Thyroid stimulating hormone fusion proteins |
| 03/11/2010 | WO2009095646A3 Peptides from factor viii |
| 03/11/2010 | WO2009071912A3 Material comprising nm23 linked to a substrate for use in treating neuron disorders |
| 03/11/2010 | WO2009069133A3 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 03/11/2010 | WO2009050486A3 F0xp3 : nfat inhibitor peptides for the treatment of cancer |
| 03/11/2010 | WO2009023055A3 Blockade of the inhibitory qa-1-cd94/nkg2a pathway for treatment of autoimmune disease |
| 03/11/2010 | WO2009021293A8 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
| 03/11/2010 | WO2007078633A3 Bacteriocin inducer peptides |
| 03/11/2010 | US20100063459 Gelatin-transglutaminase hemostatic dressings and sealants |
| 03/11/2010 | US20100063260 Whitefly Ecdysone Receptor Antibody |
| 03/11/2010 | US20100063259 Compositions and methods for diagnosing or treating psoriasis |
| 03/11/2010 | US20100063255 Canola Protein Isolate Compositions |
| 03/11/2010 | US20100063010 Method for administering a spill resistant pharmaceutical system |
| 03/11/2010 | US20100062987 Anticonvulsive pharmaceutical compositions |
| 03/11/2010 | US20100062986 Method to treat blood cell depletion |
| 03/11/2010 | US20100062985 Agents and methods for treating pain |
| 03/11/2010 | US20100062984 Fgf-23 polypeptides |
| 03/11/2010 | US20100062983 Use of Factor VIIa or Factor VIIa equivalents for treating late complications of trauma |
| 03/11/2010 | US20100062982 Avian derived fusion proteins |
| 03/11/2010 | US20100062981 Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion |
| 03/11/2010 | US20100062980 Therapeutic uses of beta-antagonists |
| 03/11/2010 | US20100062979 Treatment of ectoparasitic infestation |
| 03/11/2010 | US20100062978 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
| 03/11/2010 | US20100062977 TCR-Independent Activation of T Cells |
| 03/11/2010 | US20100062976 Synthesis of Cyclosporin Analogs |
| 03/11/2010 | US20100062975 Method for the treatment and prevention of ocular disorders |
| 03/11/2010 | US20100062974 Combination therapy for the treatment of bacterial infections |
| 03/11/2010 | US20100062972 Triazole compounds and uses related thereto |
| 03/11/2010 | US20100062971 such as 2-{3-[2-(4-Methoxy-phenyl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta -D-glucopyranoside, used for for treating diabetes, Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders |
| 03/11/2010 | US20100062970 Synthesis of propyl phenoxy ethers and use as delivery agents |
| 03/11/2010 | US20100062969 Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| 03/11/2010 | US20100062968 Novel strategies for delivery of active agents using micelles and particles |
| 03/11/2010 | US20100062967 Coated lipid complexes and their use |
| 03/11/2010 | US20100062531 RGD Containing Recombinant Gelatin |
| 03/11/2010 | US20100062487 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 03/11/2010 | US20100062448 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 03/11/2010 | US20100062081 Use of tellurium containing compounds as nerve protecting agents |
| 03/11/2010 | US20100062071 Particle Formulations and Uses Thereof |
| 03/11/2010 | US20100062059 S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions |
| 03/11/2010 | US20100062058 Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same |
| 03/11/2010 | US20100062052 Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
| 03/11/2010 | US20100062050 Means and methods of enhancing delivery to biological systems |
| 03/11/2010 | US20100062048 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds |
| 03/11/2010 | US20100062047 Composition for Administration to Mammals or Human |
| 03/11/2010 | US20100062037 Subcutaneous implants releasing an active principle over an extended period of time |
| 03/11/2010 | US20100062027 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 03/11/2010 | US20100062024 Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use |
| 03/11/2010 | US20100062013 Cancer antigen peptides derived from wt1 |
| 03/11/2010 | US20100062009 for cancer, immune, infectious and ischemic diseases; inhibiting tumor growth; allergy |
| 03/11/2010 | US20100062003 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/11/2010 | US20100062000 Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations |
| 03/11/2010 | US20100061999 Antihuman tnf-alpha antibody activity lowering inhibitor |
| 03/11/2010 | US20100061997 Transgenic Non-Human Animals Expressing A Truncated Activin Type II Receptor |
| 03/11/2010 | US20100061996 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 03/11/2010 | US20100061994 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 03/11/2010 | US20100061992 Therapeutic uses of tim-3 modulators |
| 03/11/2010 | US20100061989 Method of treatment and prophylaxis |
| 03/11/2010 | US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 03/11/2010 | US20100061984 Compositions and methods for modulation of suppressor t cell activation |
| 03/11/2010 | US20100061983 Method of inhibiting leukocytes with human cxc chemokine receptor 3 antibody |
| 03/11/2010 | US20100061981 p75NTR MEDIATES EPHRIN-A REVERSE SIGNALING |
| 03/11/2010 | US20100061977 Methods and compositions for treating and diagnosing diseases |
| 03/11/2010 | US20100061976 Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| 03/11/2010 | US20100061973 Graded Expression of Snail as Marker of Cancer Development and DNA Damage-Based Diseases |
| 03/11/2010 | US20100061972 Method of Treating Peyronie's Disease |
| 03/11/2010 | US20100061971 Method for Treating Human Diseases Associated With an Increased Deoxyribonucleic Acid Content in Extracellular Spaces of Tissues and a Medicinal Preparation for Carrying Out Said Method |
| 03/11/2010 | US20100061970 CBLB for Treating Endotoxin-Mediated Disorders |
| 03/11/2010 | US20100061969 Dietary supplement, anti-fatigue agent or physical endurance enhancer, functional food, or cosmetic |